Stephen Oh, MD, PhD, and colleagues have identified a potential approach to treat a group of blood cancers known as myeloproliferative neoplasms by taming inflammation.
Stephen Oh, MD, PhD, and colleagues have identified a potential approach to treat a group of blood cancers known as myeloproliferative neoplasms by taming inflammation.